+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin

Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin

Vaccine 20(5-6): 756-762, 12 December

We demonstrated that the mutant of cholera toxin (mCT) E112K which was LPS-free supported the induction of protective immunity in mucosal (e.g. lung lavage) and systemic (e.g. serum) compartments when given nasally with vaccine-grade diphtheria toxoid (DT) to mice. Significant DT-specific mucosal IgA antibody (Ab) and serum IgG, IgA and IgM Ab responses were induced when LPS-depleted mCT E112K or native CT (nCT) was co-administered nasally with DT. The analysis of DT-specific Ab-forming cell (AFC) responses supported the Ab titers and significant numbers of DT-specific IgA AFC were present in the lungs, nasal passages and submandibular glands. Furthermore, DT-specific IgG AFC in cervical lymph nodes (CLN) and the spleen were induced in mice administered with DT nasally with either mCT or nCT. The analysis of antigen-specific T cell responses revealed that increased DT-specific CD4+ T cell proliferative and Th2-type cytokine responses were induced in mice nasally-immunized with DT and the LPS-free form of mCT. The neutralization of diphtheria toxin by Abs showed that DT-specific IgG Ab responses in serum and lung lavages of mice immunized with DT and mCT were protective. Furthermore, it was shown that an IgA-enriched fraction of lung lavages possessed diphtheria toxin-specific neutralizing activity. These results are the first demonstration that nasally co-administered mCT E112K can induce DT-specific protective Ab responses in mucosal compartments (e.g. lung lavages and the lungs).

Accession: 010754559

Download citation: RISBibTeXText

PMID: 11738739

DOI: 10.1016/s0264-410x(01)00412-1

Download PDF Full Text: Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin

Related references

A nontoxic mutant of cholera toxin elicits mucosal immunity to vaccines given intranasally. Journal of Allergy & Clinical Immunology 99(1 PART 2): S35, 1997

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proceedings Of The National Academy Of Sciences Of The United States Of America. 94(10): 5267-5272, 1997

A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models. Vaccine 30(28): 4249-4258, 2012

Study of diphtheria toxin and anti toxin part 3 immunological efficacy of sorbed preparations made on the basis of highly purified diphtheria toxoid. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(4): 7-12, 1972

Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin. Infection and Immunity 60(12): 5071-5077, 1992

The adjuvant effect of cholera toxin cholera toxin b subunit and glutaraldehyde modified cholera toxin on the mucosal immune response of rabbits to 2 acetylaminofluorene thyroglobulin conjugates. FASEB Journal 4(3): A500, 1990

Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. Journal of Immunology 155(6): 2877-2887, 1995

Intragastric immunization with recombinant H pylori urease formulated with attenuated cholera toxin elicits systemic, mucosal and protective immune responses in C57BL/6 mice. FASEB Journal 13(4 PART 1): A291, March 12, 1999

Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity. Vaccine 27(43): 5982-5988, 2009

Evaluation of purified cholera toxins and toxoids as immunizing agents against cholera and development of a new technique for measuring cholera toxin toxoid and anti toxin. U S Government Research & Development Reports 71(5): 43, 1971

Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin. Journal of Biochemistry 142(1): 105-112, 2007

Effects of pseudomonas aeruginosa toxin a diphtheria toxin and cholera toxin on electrical characteristics of turtle pseudemys scripta bladder. Proceedings of the National Academy of Sciences of the United States of America 76(7): 3562-3566, 1979